title: Comment on complications following antidotal use of intravenous lipid emulsion therapy (Levine et Al., J Med Toxicol 2013).
authors: McGill University Health Centre, Montreal, Quebec, Canada, ami.grunbaum@mail.mcgill.ca.
authors: Ami M
authors: AM
authors: Grunbaum
authors: Sophie
authors: S
authors: Gosselin
authors: Brian M
authors: BM
authors: Gilfix
authors: David W
authors: DW
authors: Blank
mesh_terms: D000931:Antidotes / Q000009:adverse effects*; D005217:Fat Emulsions, Intravenous / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology*; D008297:Male; D010195:Pancreatitis / Q000209:etiology*; D012128:Respiratory Distress Syndrome / Q000209:etiology*
chemical_list: D000931:Antidotes; D005217:Fat Emulsions, Intravenous